News & Perspective

Oct 18, 2005

Oct 18, 2005

Roche to build Tamiflu plant in US

(CIDRAP News) – The Swiss pharmaceutical company Roche announced today it would build a plant in the United States to make oseltamivir (Tamiflu) and also consider licensing other companies to make the drug in the face of a possible flu pandemic.

Jul 05, 2006

Jul 05, 2006

HHS has enough H5N1 vaccine for 4 million people

(CIDRAP News) – In an update on pandemic influenza preparedness efforts, the federal government said last week it had stockpiled enough vaccine against H5N1 avian influenza virus to inoculate about 4 million people and enough antiviral medication to treat about 6.3 million.

Jul 18, 2006

Jul 18, 2006

Novartis to build US cell-based flu vaccine plant

(CIDRAP News) – Novartis, the Swiss-based drug manufacturer, today announced plans to build what it says will be the first US plant to make cell-culture-based influenza vaccines.

The facility will be built in Holly Springs, N.C., at a total cost of about $600 million, the company said in a news release. It will be able to produce about 50 million doses of seasonal trivalent (three-strain) flu vaccine annually.

Oct 02, 2006

Oct 02, 2006

Injectable drug seen as potential treatment for flu, both seasonal and avian

(CIDRAP News) – Recent tests suggest that an antiviral drug given by intravenous (IV) or intramuscular (IM) injection could eventually serve as another weapon against influenza, according to results presented at a conference last week.

Oct 02, 2006

FDA issues guide to ease production of cell-based vaccines

(CIDRAP News) – In a major push to modernize and speed the production of vaccines for pandemic influenza and other emerging threats, the US Food and Drug Administration (FDA) last week issued new guidance on how to safely and effectively develop new cell-based vaccines.

Jul 17, 2007

Jul 17, 2007

White House issues 1-year status report on pandemic planning

(CIDRAP News) – The White House Homeland Security Council today released a 1-year update on the federal government's pandemic influenza preparedness strategy, reporting that it has met 86% of the objectives it set for itself a year ago.

Jul 19, 2007

Jul 19, 2007

HHS updates pandemic stockpile totals and planning efforts

(CIDRAP News) – In an update on the nation's pandemic preparedness efforts, the US Department of Health and Human Services (HHS) yesterday said it had stockpiled enough H5N1 avian influenza vaccine to protect about 6 million people and that federal and state supplies contain enough antiviral medication to treat more than 48 million.

Dec 18, 2007

Dec 18, 2007

Funding cuts said to threaten states' preparedness progress

(CIDRAP News) – Several states have made progress preparing for a major public health emergency such as a pandemic or bioterror attack, but funding shortfalls at the federal level threaten to stall or even reverse recent gains, according to a report today from the nonprofit organization Trust for America's Health (TFAH).

Apr 25, 2008

Apr 25, 2008

IOM: US likely to need bigger antiviral stockpile

(CIDRAP News) – The US government will need to expand its stockpile of antiviral drugs if the goal is to have enough doses to treat all patients and provide preventive treatment for some others at risk in an influenza pandemic, the Institute of Medicine (IOM) says in a report issued today.

Oct 03, 2008

Oct 03, 2008

Plant cancellation shows problems in flu vaccine business

(CIDRAP News) – A flu vaccine manufacturer's decision not to build a US facility has highlighted the perpetual mismatch between flu-shot supply and demand—and the reality that the mismatch may undermine plans for pandemic flu vaccines.

Pages

by Topic

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»